Austin Medical Technologies, Inc. Breaks The 200 Mark, By Adding 12 New Contracts In The Month Of June

PLANO, Texas, June 21 /PRNewswire-FirstCall/ -- AUSTIN MEDICAL TECHNOLOGIES, Inc. (OTC Pink Sheets: AMTK), dba eyeDirecti, announces 12 new contracts in June. All the contracts are multi year contracts, providing an additional $500,000.00 of new business.

Kurt Tarter, President & CEO, states, "We are happy to see the addition of these new customers to our existing base and we expect to see continued large gains in our sales. With the addition of over 200 surgery centers, as a result of these contracts, we have stronger buying power to improve our margins and leverage our new products penetration."

About Austin Medical Technologies, Inc./eyeDirecti(TM) (Brand)

Austin Medical Technologies delivers "DIRECT" from the manufacturer to the Surgeon, the only technology based, "Single Source Supply Solution" for custom sterile surgery trays made up of 80% of all disposable surgical devices utilized in surgery. Currently the company has contracted with 200 eye surgery centers including the 2 largest eye surgery centers in the USA. The market for custom sterile surgery trays is a $2.1 Billion market here in the USA.

Austin Medical is dedicated exclusively to the Ambulatory Surgery Center (ASC) market. Ambulatory Surgery Centers (ASC), also called outpatient surgery, and same-day surgery, refers to surgical procedures which are complex enough to require a dedicated operating room and specially trained staff, but do not require an overnight stay. According to 1996 U.S. government statistics, ambulatory surgery centers account for 31 million or 44% of the total surgeries performed in the United States. Five million surgeries were performed on eyes. New surgical techniques such as laser surgery allow procedures to be done more quickly and/or with less surgical trauma.

Under the brand name eyeDirecti, Austin Medical is initially focused on Ophthalmology owned and operated surgery centers which is the fastest growing segment of the ASC market, growing by 25% per annum, consisting of 2,500 practices with 15,000 surgeons performing over 5 million surgical procedures annually at a supply cost of $400,000,000 per year. Austin Medical is positioned to capture $40,000,000 (10%) of this $400,000,000 market within the next 4 years. Visit our e-commerce site at http://www.eyedirecti.com/

Note: Any statements released by Austin Medical Technologies, Inc, or any of its affiliates that are forward-looking, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act. Editors and investors are cautioned that forward-looking statements invoke risk and uncertainties that may affect the Company's business prospects and performances. These include economic, competitive, governmental, technological and other factors discussed in the statements and in the Company's filings with the Securities and Exchange Commission.

Austin Medical Technologies, Inc.

CONTACT: Keith Tarter of Austin Medical Technologies, Inc.,+1-972-370-0197, or investors@austinmedtech.com

Back to news